A Study of HDM2020 in Patients With Advanced Sq-NSCLC

Clinical trial NCT07638891 · RECRUITING

Trial details

NCT number: NCT07638891
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Non-small Cell Lung Cancer(NSCLC)

Start date: 2026-04-01
Primary completion: 2027-01-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.